| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 2, 2005
Accepted on December 7, 2005
From the Department of Cell Biology (WL.G., G.B., J.D.S.), Cleveland Clinic Foundation, Cleveland, Ohio; the Department of Rheumatology (P.Z.), New York University School of Medicine, New York, NY; and the Department of Molecular Medicine (J.D.S.), Case Western Reserve University School of Medicine, Cleveland Ohio.
* To whom correspondence should be addressed. E-mail: smithj4{at}ccf.org.
Objective--To determine the mechanism by which expression of the murine ABCA1 gene is highly induced by cAMP analogues.
Methods and Results--ABCA1 mRNA turnover cannot account for its induction by cAMP. Thus cAMP induction of ABCA1 mRNA occurs at a transcriptional level. Shotgun cloning DNA fragments from the murine ABCA1 locus identified a strong cAMP responsive enhancer located in the first intron, which led to 25- to 100-fold cAMP-mediated induction of reporter gene activity. Deletions and mutations of this enhancer led to the identification a cAMP-responsive element (CRE) that was essential for the cAMP induction. Furthermore, the capacity of this CRE site to mediate the cAMP induction required the presence of a STAT3/4 element located 81 bp away. A dominant-negative CREB expression vector inhibited the cAMP induction of ABCA1, demonstrating that CREB was required for cAMP induction of ABCA1 expression in RAW264.7 cells.
Conclusion--Phospho-CREB1 controls the cAMP-mediated induction of murine ABCA1 gene expression through a CRE site acting in cooperation with a nearby STAT element. This CRE site is not conserved in the human ABCA1 gene, explaining why human ABCA1 is not strongly stimulated by cAMP analogs.
This article has been cited by other articles:
![]() |
S. Larrede, C. M. Quinn, W. Jessup, E. Frisdal, M. Olivier, V. Hsieh, M.-J. Kim, M. Van Eck, P. Couvert, A. Carrie, et al. Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-Independent Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1930 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nandi, L. Ma, M. Denis, J. Karwatsky, Z. Li, X.-C. Jiang, and X. Zha ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity J. Lipid Res., March 1, 2009; 50(3): 456 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar, D. McClain, R. Young, and G. A. Carlson Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells J. Gen. Virol., June 1, 2008; 89(6): 1525 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-D. Wang, V. Franklin, M. Sundaram, R. S. Kiss, K. Ho, M. Gallant, and Y. L. Marcel Differential Regulation of ATP Binding Cassette Protein A1 Expression and ApoA-I Lipidation by Niemann-Pick Type C1 in Murine Hepatocytes and Macrophages J. Biol. Chem., August 3, 2007; 282(31): 22525 - 22533. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iwamoto, S. Abe-Dohmae, M. Ayaori, N. Tanaka, M. Kusuhara, F. Ohsuzu, and S. Yokoyama ATP-Binding Cassette Transporter A1 Gene Transcription Is Downregulated by Activator Protein 2{alpha}: Doxazosin Inhibits Activator Protein 2{alpha} and Increases High-Density Lipoprotein Biogenesis Independent of {alpha}1-Adrenoceptor Blockade Circ. Res., July 20, 2007; 101(2): 156 - 165. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |